Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives

Journal of Clinical Epidemiology

Volumn 58, Issue 6, 2005, Pages 560-567

  Wieland, Susan ^a   Dickersin, Kay ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Adverse events; Information storage and retrieval; Medline searching; Observational studies; Precision; Sensitivity; Systematic reviews

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; MEDROXYPROGESTERONE; MESTRANOL; ORAL CONTRACEPTIVE AGENT;

ACCURACY; ADVERSE DRUG REACTION; BREAST CANCER; CLINICAL RESEARCH; HUMAN; MEDLINE; PRIORITY JOURNAL; REVIEW;

EID: 18844448217     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2004.11.018     Document Type: Article

References (78)

1. C.E. Adams, A. Power, K. Frederick, and C. Lefebvre An investigation of the adequacy of Medline searches for randomized controlled trials (RCTs) of the effects of mental health care Psychol Med 24 1994 741 748
2. K. Dickersin, R. Scherer, and C. Lefebvre Identifying relevant studies for systematic reviews BMJ 309 1994 1286 1291
3. P.J. Hay, C.E. Adams, and C. Lefebvre The efficiency of searches for randomized controlled trials in the International Journal of Eating Disorders: a comparison of handsearching, EMBASE and PsycLIT Health Libr Rev 13 1996 91 96
4. D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, D. Elbourne, P.C. Gøtzsche, and T. Lang CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Int Med 134 2001 663 694
5. An evidence based health care system: the case for clinical trials registries. A Technology assessment workshop; Bethesda, MD; Dec. 6-7, 1993. Bethesda, MD: National Institutes of Health, Office of Medical Applications of Research; 1994. Available at: http://consensus.nih.gov/ta/013/013_statement.htm.
6. R.B. Haynes, N. Wilczynski, K.A. McKibbon, C.J. Walker, and J.C. Sinclair Developing optimal search strategies for detecting clinically sound studies in MEDLINE J Am Med Inform Assoc 1 1994 447 458
7. A. McKibbon PDQ evidence-based principles and practice 1999 B.C. Decker Hamilton, ON, Canada
8. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Lancet 347 1996 1713 1727
9. F.E. Alexander, M.M. Roberts, and A. Huggins Risk factors for breast cancer with applications to selection for the prevalence screen J Epidemiol Community Health 41 1987 101 106
10. L.A. Brinton, J.R. Daling, J.M. Liff, J.B. Schoenberg, K.E. Malone, J.L. Stanford, R.J. Coates, M.D. Gammon, L. Hanson, and R.N. Hoover Oral contraceptives and breast cancer risk among younger women J Natl Cancer Inst 87 1995 827 835
11. R.C. Brownson, C.W. Blackwell, D.K. Pearson, R.D. Reynolds, J.W. Richens Jr., and B.W. Papermaster Risk of breast cancer in relation to cigarette smoking Arch Intern Med 148 1988 140 144
12. E.E. Calle, L.M. Martin, M.J. Thun, H.L. Miracle, and C.W. Heath Jr. Family history, age, and risk of fatal breast cancer Am J Epidemiol 138 1993 675 681
13. F. Clavel, N. Andrieu, B. Gairard, A. Bremond, L. Piana, J. Lansac, G. Breart, C. Rumeau-Rouquette, R. Flamant, and R. Renaud Oral contraceptives and breast cancer: a French case-control study Int J Epidemiol 20 1991 32 38
14. M. Ewertz Oral contraceptives and breast cancer risk in Denmark Eur J Cancer 28A 1992 1176 1181
15. N.V. Harris, N.S. Weiss, A.M. Francis, and L. Polissar Breast cancer in relation to pattern of oral contraceptive use Am J Epidemiol 116 1982 643 651
16. R.E. Harris, E.A. Zang, and E.L. Wynder Oral contraceptives and breast cancer risk: a case-control study Int J Epidemiol 19 1990 240 246
17. R.A. Hiatt, R. Bawol, G.D. Friedman, and R. Hoover Exogenous estrogen and breast cancer after bilateral oophorectomy Cancer 54 1984 139 144
18. T.G. Hislop, A.J. Coldman, J.M. Elwood, G. Brauer, and L. Kan Childhood and recent eating patterns and risk of breast cancer Cancer Detect Prev 9 1986 47 58
19. D.T. Janerich, A.P. Polednak, D.M. Glebatis, and C.E. Lawrence Breast cancer and oral contraceptive use: a case-control study J Chronic Dis 36 1983 639 646
20. S.S. Jick, A.M. Walker, A. Stergachis, and H. Jick Oral contraceptives and breast cancer Br J Cancer 59 1989 618 621
21. C.R. Kay, and P.C. Hannaford Breast cancer and the pill: a further report from the Royal College of General Practitioners' Oral Contraception Study Br J Cancer 58 1988 675 680
22. J.L. Kelsey, T.R. Holford, C. White, E.S. Mayer, S.E. Kilty, and R.M. Acheson Oral contraceptives and breast disease: an epidemiological study Am J Epidemiol 107 1978 236 244
23. C. La Vecchia, E. Negri, S. Franceschi, R. Talamini, D. Amadori, R. Filiberti, E. Conti, M. Montella, A. Veronesi, and F. Parazzini Oral contraceptives and breast cancer: a cooperative Italian study Int J Cancer 60 1995 163 167
24. H.P. Lee, L. Gourley, S.W. Duffy, J. Esteve, J. Lee, and N.E. Day Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore Cancer Causes Control 3 1992 313 322
25. N.C. Lee, L. Rosero-Bixby, M.W. Oberle, C. Grimaldo, A.S. Whatley, and E.Z. Rovira A case-control study of breast cancer and hormonal contraception in Costa Rica J Natl Cancer Inst 79 1987 1247 1254
26. E. Marubini, A. Decarli, A. Costa, C. Mazzoleni, C. Andreoli, A. Barbieri, E. Capitelli, M. Carlucci, F. Cavallo, N. Monferroni, U. Pastorino, and S. Salvini The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer: results of a case-control study Cancer 61 1988 173 180
27. K. McPherson, M.P. Vessey, A. Neil, R. Doll, L. Jones, and M. Roberts Early oral contraceptive use and breast cancer: results of another case-control study Br J Cancer 56 1987 653 660
28. O. Meirik, E. Lund, H.O. Adami, R. Bergstrom, T. Christoffersen, and P. Bergsjo Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway Lancet 2 8508 1986 650 654
29. A.B. Miller, C.J. Baines, T. To, and C. Wall Canadian National Breast Screening Study I, breast cancer detection and death rates among women aged 40-49 years CMAJ 147 1992 1459 1476 [Erratum in: CMAJ 1993; 148:718]
30. P.K. Mills, W.L. Beeson, R.L. Phillips, and G.E. Fraser Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists Cancer 64 1989 591 597
31. A. Morabia, M. Szklo, W. Stewart, L. Schuman, and D.B. Thomas Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls Prev Med 22 1993 178 186
32. P.A. Newcomb, B.E. Storer, M.P. Longnecker, R. Mittendorf, E.R. Greenberg, R.W. Clapp, K.P. Burke, W.C. Willett, and B. MacMahon Lactation and a reduced risk of premenopausal breast cancer N Engl J Med 330 1994 81 87
33. A.M. Nomura, L.N. Kolonel, T. Hirohata, and J. Lee The association of replacement estrogens with breast cancer Int J Cancer 37 1986 49 53
34. H. Olsson, T.R. Moller, and J. Ranstam Early oral contraceptive use and cancer among premenopausal women: final report from a study in southern Sweden J Natl Cancer Inst 81 1989 1000 1004
35. R.S. Paffenbarger Jr., E. Fasal, M.E. Simmons, and J.B. Kampert Cancer risk as related to use of oral contraceptives during fertile years Cancer 39 4 Suppl 1977 1887 1891
36. C. Paul, D.C.G. Skegg, and G.F.S. Spears Oral contraceptives and risk of breast cancer Int J Cancer 46 1990 366 373
37. M.C. Pike, B.E. Henderson, M.D. Krailo, A. Duke, and S. Roy Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use Lancet 2 8356 1983 926 930
38. M. Primic-Zakelj, T. Evstifeeva, B. Ravnihar, and P. Boyle Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54 Int J Cancer 62 1995 414 420
39. B. Ravnihar, D.G. Seigel, and J. Lindtner An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use Eur J Cancer 15 1979 395 405
40. B. Ravnihar, M. Primic-Zakelj, K. Kosmelj, and J. Stare A case-control study of breast cancer in relation to oral contraceptive use in Slovenia Neoplasma 35 1988 109 121
41. T.E. Rohan, and A.J. McMichael Oral contraceptive agents and breast cancer: a population-based case-control study Med J Aust 149 1988 520 526
42. I. Romieu, W.C. Willett, G.A. Colditz, M.J. Stampfer, B. Rosner, C.H. Hennekens, and F.E. Speizer Prospective study of oral contraceptive use and the risk of breast cancer in women J Natl Cancer Inst 81 1989 1313 1321
43. M.A. Rookus, F.E. van Leeuwen, and Netherlands Oral Contraceptives and Breast Cancer Study Group Oral contraceptives and risk of breast cancer in women aged 20-54 years Lancet 344 1994 844 851
44. L. Rosenberg, J.R. Palmer, E.A. Clarke, and S. Shapiro A case-control study of the risk of breast cancer in relation to oral contraceptive use Am J Epidemiol 136 1992 1437 1444
45. R.K. Ross, A. Paganini-Hill, V.R. Gerkins, T.M. Mack, R. Pfeffer, M. Arthur, and B.E. Henderson A case-control study of menopausal estrogen therapy and breast cancer JAMA 243 1980 1635 1639
46. P.E. Sartwell, F.G. Arthes, and J.A. Tonascia Exogenous hormones, reproductive history, and breast cancer J Natl Cancer Inst 59 1977 1589 1592
47. J.M. Schildkraut, B.S. Hulka, and W.E. Wilkinson Oral contraceptives and breast cancer: a case-control study with hospital and community controls Obstet Gynecol 76 1990 395 402
48. A.G. Schuurman, P.A. van den Brandt, and R.A. Goldbohm Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study Cancer Causes Control 6 1995 416 424
49. C. Segala, M. Gerber, and S. Richardson The pattern of risk factors for breast cancer in a Southern France population: interest for a stratified analysis by age at diagnosis Br J Cancer 64 1991 919 925
50. V. Siskind, F. Schofield, D. Rice, and C. Bain Breast cancer and breastfeeding: results from an Australian case-control study Am J Epidemiol 130 1989 229 236
51. J.L. Stanford, L.A. Brinton, and R.N. Hoover Oral contraceptives and breast cancer: results from an expanded case-control study Br J Cancer 60 1989 375 381
52. R. Talamini, C. La Vecchia, S. Franceschi, F. Colombo, A. Decarli, E. Grattoni, E. Grigoletto, and G. Tognoni Reproductive and hormonal factors and breast cancer in a Northern Italian population Int J Epidemiol 14 1985 70 74
53. A. Tavani, E. Negri, S. Franceschi, F. Parazzini, and C. La Vecchia Oral contraceptives and breast cancer in northern Italy: final report from a case-control study Br J Cancer 68 1993 568 571
54. UK National Case-Control Study Group Oral contraceptive use and breast cancer risk in young women Lancet 1 8645 1989 973 982
55. G. Ursin, C.C. Aragaki, A. Paganini-Hill, J. Siemiatycki, W.D. Thompson, and R.W. Haile Oral contraceptives and premenopausal bilateral breast cancer: a case-control study Epidemiology 3 1992 414 419
56. M. Vessey, J. Baron, R. Doll, K. McPherson, and D. Yeates Oral contraceptives and breast cancer: final report of an epidemiological study Br J Cancer 47 1983 455 462
57. M.P. Vessey, K. McPherson, L. Villard-Mackintosh, and D. Yeates Oral contraceptives and breast cancer: latest findings in a large cohort study Br J Cancer 59 1989 613 617
58. D.Y. Wang, B.L. de Stavola, R.D. Bulbrook, D.S. Allen, H.G. Kwa, A.A. Verstraeten, J.W. Moore, I.S. Fentiman, M. Chaudary, J.L. Hayward, and I.H. Gravelle The relationship between blood prolactin levels and risk of breast cancer in premenopausal women Eur J Clin Oncol 23 1987 1541 1548
59. Q.-S. Wang, R.K. Ross, M.C. Yu, J.-P. Ning, B.E. Henderson, and H.T. Kimm A case-control study of breast cancer in Tianjin, China Cancer Epidemiol Biomarkers Prev 1 1992 435 439
60. A.L. Weinstein, M.C. Mahoney, P.C. Nasca, M.C. Leske, and A.O. Varma Breast cancer risk and oral contraceptive use: results from a large case-control study Epidemiology 2 1991 353 358
61. E. White, K.E. Malone, N.S. Weiss, and J.R. Daling Breast cancer among young U.S. women in relation to oral contraceptive use J Natl Cancer Inst 86 1994 505 514
62. WHO Collaborative Study of Neoplasia and Steroid Contraceptives Breast cancer and combined oral contraceptives: results from a multinational study Br J Cancer 61 1990 110 119
63. P.A. Wingo, N.C. Lee, H.W. Ory, V. Beral, H.B. Peterson, and P. Rhodes Age-specific differences in the relationship between oral contraceptive use and breast cancer Obstet Gynecol 78 1991 161 170
64. E.L. Wynder, F.A. MacCornack, and S.D. Stellman The epidemiology of breast cancer in 785 United States Caucasian women Cancer 41 1978 2341 2354
65. C.P. Yang, J.R. Daling, P.R. Band, R.P. Gallagher, E. White, and N.S. Weiss Noncontraceptive hormone use and risk of breast cancer Cancer Causes Control 3 1992 475 479
66. J.M. Yuan, M.C. Yu, R.K. Ross, Y.T. Gao, and B.E. Henderson Risk factors for breast cancer in Chinese women in Shanghai Cancer Res 48 1988 1949 1953
67. Indexing operation. Chapter 4. In: Indexing Manual [Internet]. Bethesda, MD: National Library of Medicine. Available at: http://www.nlm.nih.gov/mesh/ indman/chapter_4.html (accessed June 29, 2004).
68. R.J.D. Watson, and P.H. Richardson Accessing the literature on outcome studies in group psychotherapy: the sensitivity and precision of Medline and PsycINFO bibliographic database searching Br J Med Psychol 72 1999 127 134
69. S. Derry, Y.K. Loke, and J.K. Aronson Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials BMC Med Res Methodol 1 1 2001 7
70. S. Hahn, P.R. Williamson, J.L. Hutton, P. Garner, and E.V. Flynn Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies Stat Med 19 2000 3325 3336
71. J.L. Hutton, and P.R. Williamson Bias in meta-analysis due to outcome variable selection within studies Appl Stat 49 2000 359 370
72. A.W. Chan, A. Hrobjartsson, M.T. Haahr, P.C. Gotzsche, and D.G. Altman Empirical evidence for selective reporting of outcomes in randomized controlled trials: comparison of protocols to published articles JAMA 291 2004 2457 2465
73. K. McPherson, and E. Hemminki Synthesising licensing data to assess drug safety BMJ 328 2004 518 520
74. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, and S.B. Thacker Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
75. D.C. Des Jarlais, C. Lyles, N. Crepaz, and TREND Group Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement Am J Public Health 94 2004 361 366
76. K.A. Robinson, and K. Dickersin Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed Int J Epidemiol 31 2002 150 153
77. K. Dickersin, E. Manheimer, S. Wieland, K.A. Robinson, C. Lefebvre, and S. McDonald Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials Eval Health Prof 25 2002 38 64
78. Y.K. Loke, and S. Derry Reporting of adverse drug reactions in randomised controlled trials: a systematic survey BMC Clin Pharmacol 1 1 2001 3